{"investor":{"slug":"trumed-investment","name":"TruMed Investment","website":null,"x_handle":null,"logo":null,"type":"fund","companies":1,"deals":1,"deals_12m":1,"deals_90d":1,"leads":0,"round_capital":80000000,"latest_deal":{"date":"2026-09-07","stage":"series-b+","amount_usd":80000000,"company":{"slug":"neushen-therapeutics","name":"NeuShen Therapeutics"}}},"profile":null,"fund_returns":[],"funds_raised":[],"team":[],"limited_partners":[],"positions":[],"portfolio":[{"slug":"neushen-therapeutics","name":"NeuShen Therapeutics","logo":"https://recentfunding.com/logo/e/X46-rSVltEzdv7kvobB418jBltuKW8K6XI1grDfOpTV8EpwtdYVxjtPdtdUaeTi3lX9qdJzs0NMeCqLDM0qGtLkF-hlaKyxR0FKUH4fEyd-S9LTh_j2I5CjprA","crypto":false,"categories":["health-bio"],"total_raised":100000000,"latest_raise":{"date":"2026-09-07","stage":"series-b+","amount_usd":80000000,"source_url":"https://www.thepharmaletter.com/biotech-news/neushen-closes-oversubscribed-series-b-exceeding-80-million-for-cns-pipeline"},"rounds_with_investor":[{"date":"2026-09-07","stage":"series-b+","amount_usd":80000000,"source_url":"https://www.thepharmaletter.com/biotech-news/neushen-closes-oversubscribed-series-b-exceeding-80-million-for-cns-pipeline","lead":false}]}],"top_categories":[{"key":"health-bio","label":"Health and bio","companies":1,"share":1}],"allocation":{"stages":[{"key":"series-b+","label":"Series B+","deals":1,"capital":80000000,"share":1}],"years":[{"year":"2026","deals":1,"capital":80000000,"share":1}]},"co_investors":[{"slug":"b-capital","name":"B Capital","logo":"https://recentfunding.com/logo/e/y5S-bv_z20vVCVfz9xNUw_IgGha5tnBjSJO5IrFmYiHSbe6d9C3SEUKSZ3fTEzATcKA2PqoOu9TPAENLW4ELhcLhhkvFJBRjX7EZxrcuhtupDYFQzwCjVA1rxXLK7hix","type":"fund","shared_rounds":1,"last_shared":"2026-09-07"},{"slug":"matrix-partners-china","name":"Matrix Partners China","logo":"https://recentfunding.com/logo/e/k8mdwvQvZc8ZXUXbbKZZQVaxpmfol1HK2skNFECT59hOwxXiy5d2ESkVKz4xVSAYHa1eG687Kqgl3G2jt9R3KrIn1Xu7kSmsHDa-hZD2m5Hm9XAlCl7gNi74MDFV5iacUwaPuzFEUpx-QzuE4_bZxaVw74E_O7M","type":"fund","shared_rounds":1,"last_shared":"2026-09-07"},{"slug":"shanghai-guotou-pioneer","name":"Shanghai Guotou Pioneer","logo":"https://recentfunding.com/logo/e/otpEuWiu9MlAW0F8by1Crixeni9iWWM8hpFtpOe9Xtz4ly6ikiQui3doRDgCRjOEInKPR7dQz_AfcmL9ur5o51fa5zcLItJZxVzPY9rf6EW5XP08fhPziwwnyMKaMuAX-faQwUaDSw","type":"fund","shared_rounds":1,"last_shared":"2026-09-07"},{"slug":"lilly-asia-ventures","name":"Lilly Asia Ventures","logo":"https://recentfunding.com/logo/e/OlKTcHUiI4lTxbJ0XgS48bUUICQV3SIFm4eH9C7tHUVpQKzQ6N0VbgMNJ7_O1fN58ZF2aUAYdB-YIcr8Nv3dmmUyOIB6EyVJIig8pItKYQBdnFVl6ShT66eGI556HoCTEtoHRVCsHDgD8uyKPvCTQFc1QzDPPIQ","type":"fund","shared_rounds":1,"last_shared":"2026-09-07"},{"slug":"legend-capital","name":"Legend Capital","logo":"https://recentfunding.com/logo/e/bHqZaitZrLwRjBc4WzjAWK7mBAztF9g2v_epO9nBiJoX1XyG6ogtVdk9tnwtdujssnw6UQgKWM0i11S7jqXXFzLeE3MpYVFonwwW3ueMjVCF8FgQWNp4I1X7DQ","type":"fund","shared_rounds":1,"last_shared":"2026-09-07"}],"meta":{"notice":"No API key: 10000 requests a day per client, then a 429. Get a free key with just an email: POST https://recentfunding.com/api/keys/new with the JSON body {\"email\": \"you@example.com\"} (or use the form at https://recentfunding.com/api-key/). The answer's \"key\" starts with rf_; send it on every request as the header \"Authorization: Bearer rf_...\" (X-API-Key: rf_... or ?api_key=rf_... also work).","get_key":"https://recentfunding.com/api-key/","create_key":{"method":"POST","url":"https://recentfunding.com/api/keys/new","body":{"email":"you@example.com"}},"send_key":"Authorization: Bearer rf_...","daily_limit":10000,"remaining_today":9520}}